Vertigo, a common clinical symptom presenting as a sensation of self-motion or environmental movement, poses a significant diagnostic challenge in medical practice. Differentiating between peripheral and central causes of vertigo is crucial as it directly impacts patient management and prognosis.
Vertigo is primarily a symptom of vestibular dysfunction. It occurs when there's a discrepancy in the inputs from the bilateral vestibular system, visual system, and proprioceptive feedback. It's crucial for clinicians to distinguish vertigo from dizziness, as the latter is non-specific and can be a symptom of various non-vestibular disorders.
A comprehensive history and physical examination are paramount in the evaluation of vertigo. Hallmark features such as episodic vertigo, associated auditory symptoms, and triggers can be indicative of peripheral causes like benign paroxysmal positional vertigo, Meniere’s disease, or vestibular neuritis. Conversely, continuous vertigo, associated neurological symptoms, and lack of triggers often suggest central causes such as cerebellar stroke or vestibular migraine.
Diagnostic tests like the Dix-Hallpike maneuver, head impulse test, and Romberg’s test can help confirm the diagnosis. Neuroimaging and audiometry may be necessary in cases where central causes are suspected. The HINTS (Head Impulse, Nystagmus, Test of Skew) protocol is a reliable tool for distinguishing stroke from peripheral vertigo in acute settings.
Treatment of vertigo is guided by the underlying cause. Peripheral vertigo can often be managed with vestibular rehabilitation and medications like antihistamines or benzodiazepines. Central vertigo requires a more aggressive approach, often involving antiplatelet or anticoagulant therapy, and occasionally surgery.
In conclusion, a thorough understanding of vertigo's pathophysiology, a systematic approach to clinical evaluation, and appropriate diagnostic testing are vital in managing this common yet complex symptom. By adopting such a comprehensive approach, clinicians can ensure accurate diagnosis, effective treatment, and improved patient outcomes in cases of vertigo.
1.
A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.
2.
Study Homes In on Simpler Lung Cancer Screening Criteria
3.
Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment
4.
No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
5.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
1.
Bone Marrow Microenvironment Biomarkers in Hematologic Health
2.
Emerging Insights in Hematology for Better Care
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Expert Perspectives on Hematology
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation